Response in patients with SCT after pralatrexate treatment. AITL, angioimmunoblastic T-cell lymphoma; ENKT, extranodal NK/T-cell lymphoma; PTCL-NOS, peripheral T-cell lymphoma, not otherwise specified; ALCL, analplastic large T-cell lymphoma.